NEW YORK (GenomeWeb News) – Shares in Third Wave Technologies were up 13 percent, or $.31, at $2.66 in mid-afternoon trading today after the company said second-quarter revenues increased while net loss narrowed.
 
As GenomeWeb News reported this morning, Third Wave said revenues increased approximately 17 percent and net losses declined. Clinical molecular diagnostic receipts jumped 18 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.